Inactive Instrument
Bioasis Technologies Inc. Stock Toronto S.E.
Stocks
BTI.H
CA09064N1033
Biotechnology & Medical Research
OTC Markets Traded| Market Cap | 1.56M 1.11M 971K 896K 825K 107M 1.59M 10.7M 4.21M 52.38M 4.17M 4.08M 180M | P/E 2021 |
37.2x | P/E 2022 | -6.45x |
|---|---|---|---|---|---|
| Enterprise Value | 1.73M 1.23M 1.08M 994K 916K 119M 1.77M 11.88M 4.67M 58.14M 4.63M 4.53M 200M | EV / Sales 2021 |
6.07x | EV / Sales 2022 | 516x |
| Free-Float |
97.95% | Yield 2021 * |
-
| Yield 2022 | - |
| Manager | Title | Age | Since |
|---|---|---|---|
Deborah Rathjen
CEO | Chief Executive Officer | - | 2019-03-10 |
Dave Jenkins
DFI | Director of Finance/CFO | - | 2021-06-30 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -.--% | -.--% | - | - | 7.94K | |
| -1.29% | -3.11% | -0.35% | +3.09% | 49.18B | |
| +3.90% | -0.39% | +386.06% | +593.85% | 39.58B | |
| -1.70% | +4.46% | +5.93% | +60.25% | 34.69B | |
| -2.01% | -0.76% | +28.41% | -8.01% | 34.42B | |
| +0.06% | +0.34% | +2.38% | +34.38% | 27.11B | |
| +0.46% | -3.49% | - | - | 16.21B | |
| -0.04% | -0.09% | +72.42% | +115.55% | 15.36B | |
| +1.12% | +1.91% | +14.54% | +19.16% | 14.05B | |
| 0.00% | +1.36% | +18.43% | -30.79% | 13.02B | |
| Average | +0.05% | +0.03% | +65.98% | +98.43% | 27.07B | |
| Weighted average by Cap. | -0.05% | -0.18% | +79.44% | +123.32% |
| 2021 | 2022 | |
|---|---|---|
| Net sales | 4.08M 2.91M 2.54M 2.35M 2.16M 280M 4.17M 28.06M 11.04M 137M 10.93M 10.69M 473M | 37.72K 26.93K 23.53K 21.71K 20.02K 2.59M 38.56K 260K 102K 1.27M 101K 98.91K 4.37M |
| Net income | 698K 499K 436K 402K 371K 48.01M 714K 4.8M 1.89M 23.51M 1.87M 1.83M 80.94M | -2.96M -2.11M -1.85M -1.7M -1.57M -203M -3.03M -20.36M -8.01M -99.65M -7.93M -7.76M -343M |
| Net Debt | -2.62M -1.87M -1.64M -1.51M -1.39M -180M -2.68M -18.05M -7.1M -88.31M -7.03M -6.88M -304M | 171K 122K 107K 98.43K 90.72K 11.75M 175K 1.18M 463K 5.76M 458K 448K 19.82M |
Employees
-
Choose MarketScreener 
